Geron Plans to Announce Third Quarter 2026 Financial Results on November 4, 2026
FOSTER CITY, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today announced that it will release its third quarter 2026 financial results and business highlights before the market opens on Wednesday, November 4, 2026, via press release, which will be available on the Investors section of the Company’s website. Geron will host a conference call and webcast at 8:00 a.m. Eastern Time.
Covered in this story
What has happened since
- Geron Corp is down 2.6% since this was published.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $GERN yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Geron Corp →Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.